Diabetes Screening Reminder for Women With Prior Gestational Diabetes A Randomized Controlled Trial

被引:21
|
作者
Zera, Chloe A.
Bates, David W.
Stuebe, Alison M.
Ecker, Jeffrey L.
Seely, Ellen W.
机构
[1] Brigham & Womens Hosp, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02114 USA
[6] Univ N Carolina, Dept Obstet & Gynecol, Div Maternal Fetal Med, Sch Med, Chapel Hill, NC 27599 USA
来源
OBSTETRICS AND GYNECOLOGY | 2015年 / 126卷 / 01期
基金
美国国家卫生研究院;
关键词
MELLITUS; HISTORY;
D O I
10.1097/AOG.0000000000000883
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate whether an electronic health record (EHR) reminder improves rates of screening for type 2 diabetes in women with prior gestational diabetes. METHODS: We randomly allocated primary care providers (by clinic site) to a reminder for type 2 diabetes screening within the EHR or to usual care. Women with previous gestational diabetes mellitus were identified through an automated search of laboratory results and the problem list. We compared rates of screening during the study period (2010-2012) in women at intervention sites with those at control sites. With a sample size of 850 participants, we had 80% power to detect a 15% difference in screening rates. RESULTS: We included 847 individuals seen at a participating clinic during the study period, of whom 471 were at a reminder clinic and 376 were at a control clinic. A similar proportion of women were screened for type 2 diabetes in both groups (n=265, 56.3% of the reminder group compared with n=206, 54.8% of the control group, P=.67; adjusted odds ratio [OR] 1.04, 95% confidence interval [CI] 0.79-1.38). Patient characteristics associated with risk for diabetes including body mass index (adjusted OR per kg/m(2) 1.05, 95% CI 1.01-1.08) and race (adjusted OR for nonwhite race 2.14, 95% CI 1.57-2.92) were significantly associated with screening. CONCLUSION: A simple EHR reminder did not increase the rate of diabetes screening in women with prior gestational diabetes mellitus.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [31] Microalbuminuria and Adiponectin in Women with Prior Gestational Diabetes
    Gonzalez Albarran, Olga
    Calvo, Sara
    Carrasco, Marta
    Perez, Gilberto
    Gomez, Jesus
    Sancho, Jose M.
    DIABETES, 2010, 59 : A700 - A700
  • [32] One-step vs two-step screening for gestational diabetes: a randomized controlled trial
    Khalifeh, Adeeb
    Eckler, Rebecca
    Felder, Laura
    Saccone, Gabriele
    Khosla, Jayasree
    Berghella, Vincenzo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S29 - S30
  • [33] Effect of an Exercise Intervention on Gestational Diabetes Mellitus: A Randomized Controlled Trial
    Taghiof, Hamed
    Rezai, Shadi
    Henderson, Cassandra E.
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (03): : 676 - 676
  • [34] Effect of an Exercise Intervention on Gestational Diabetes Mellitus A Randomized Controlled Trial
    Nobles, Carrie
    Marcus, Bess H.
    Stanek, Edward J., III
    Braun, Barry
    Whitcomb, Brian W.
    Solomon, Caren G.
    Manson, JoAnn E.
    Markenson, Glenn
    Chasan-Taber, Lisa
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (05): : 1195 - 1204
  • [35] The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial
    Ferrara, Assiamira
    Hedderson, Monique M.
    Brown, Susan D.
    Albright, Cheryl L.
    Ehrlich, Samantha F.
    Tsai, Ai-Lin
    Caan, Bette J.
    Sternfeld, Barbara
    Gordon, Nancy P.
    Schmittdiel, Julie A.
    Gunderson, Erica P.
    Mevi, Ashley A.
    Herman, William H.
    Ching, Jenny
    Crites, Yvonne
    Quesenberry, Charles P., Jr.
    DIABETES CARE, 2016, 39 (01) : 65 - 74
  • [36] The forgotten risk? A systematic review of the effect of reminder systems for postpartum screening for type 2 diabetes in women with previous gestational diabetes
    Jeppesen C.
    Kristensen J.K.
    Ovesen P.
    Maindal H.T.
    BMC Research Notes, 8 (1)
  • [37] A Cluster Randomized Trial of Tailored Breastfeeding Support for Women with Gestational Diabetes
    Stuebe, Alison M.
    Bonuck, Karen
    Adatorwovor, Reuben
    Schwartz, Todd A.
    Berry, Diane C.
    BREASTFEEDING MEDICINE, 2016, 11 (10) : 504 - 513
  • [38] Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial
    Foghsgaard, Signe
    Vedtofte, Louise
    Andersen, Emilie S.
    Bahne, Emilie
    Andreasen, Camilla
    Sorensen, Anne L.
    Forman, Julie L.
    Mathiesen, Elisabeth R.
    Svare, Jens A.
    Clausen, Tine D.
    Damm, Peter
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 201 - 214
  • [39] The effects of metformin on weight loss in women with gestational diabetes: a pilot randomized, placebo-controlled trial
    Refuerzo, Jerrie S.
    Viteri, Oscar A.
    Hutchinson, Maria
    Pedroza, Claudia
    Blackwell, Sean C.
    Tyson, Jon E.
    Ramin, Susan M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (03) : 389.e1 - 389.e9
  • [40] Relationship among chrononutrition, sleep, and glycemic control in women with gestational diabetes mellitus: a randomized controlled trial
    Messika, Amalia
    Toledano, Yoel
    Hadar, Eran
    Shmuel, Eliassaf
    Tauman, Riva
    Shamir, Raanan
    Froy, Oren
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2022, 4 (05)